Psychiatric Bulletin (2007) 31: 176-178. doi: 10.1192/pb.bp.106.010967
© 2007 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Soyinka, A.
Right arrow Articles by Lawley, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Soyinka, A.
Right arrow Articles by Lawley, D.

Antipsychotic prescribing for behavioural and psychological symptoms of dementia

Ayodeji Soyinka, Specialist Registrar

Old Age Psychiatry, Holly House, St Mary’s Hospital, Greenhill Road, Armley, Leeds LS12 3QE, email: soyinka{at}mailcity.com

David Lawley, Consultant, Old Age Psychiatry

Humber Mental Health Teaching NHS Trust, Hull

Declaration of interest

None.

AIMS AND METHOD

To review the quality of information and advice contained in correspondence from old age psychiatrists to general practitioners (GPs) regarding the prescription of antipsychotic drugs for the management of behavioural and psychological symptoms of dementia. Discharge summaries (n=22) and subsequent out-patient review letters were examined and compared with evidence-based guidelines in two phases of an audit cycle; first in 2002 and latterly in 2005.

RESULTS

Practice was below acceptable standards during both phases of the audit cycle, with an actual drop in the quality of explicit advice given to GPs in 2005, despite national publicity about the issues and guidance from the Royal College of Psychiatrists.

CLINICAL IMPLICATIONS

The prescription of antipsychotic drugs is associated with an adverse prognosis for people with dementia. As such, it is imperative that such treatment is regularly reviewed and time limited. Old age psychiatrists need to ensure that this message is communicated to their primary care colleagues.